KMDVX yields 5.24% · JNJ yields 3.36%● Live data
📍 KMDVX pulled ahead of the other in Year 1
Combined, KMDVX + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of KMDVX + JNJ for your $10,000?
The investment seeks capital appreciation. The Adviser intends to pursue its investment objective by investing in equity securities of companies with a mid-size market capitalization and that currently pay, or are reasonably expected to pay, dividends to shareholders. The fund will invest no less than 80% of its net assets in dividend-paying common stocks and other equity type securities (including preferred stock, convertible debt securities and warrants) of mid cap companies, which the Adviser currently defines as securities within the range of the Russell Midcap® Value Index at the time of investment.
Full KMDVX Calculator →Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.